<div xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://hl7.org/fhir ../../input-cache/schemas/R5/fhir-single.xsd">
 
     <h3 id="additional-references">Additional References</h3>
  <ul>
    <li> Digital Documentation of COVID-19 Certificates: Vaccination Status: Interim Guidance. Geneva: World Health Organization (forthcoming).  </li>
    <li> Digital Documentation of COVID-19 Certificates: Vaccination Status: Interim Guidance. Web Annex A: Data Dictionary. Geneva: World Health Organization (forthcoming).  </li>
  </ul>
  
    <h4> Introduction</h4>
    <ul>
      <li> Interim international health regulations position paper. Geneva: World Health Organization (forthcoming).  </li>
      <li> Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19. Geneva: World Health Organization; 2 July 2021 <a href="https://apps.who.int/iris/handle/10665/342235">(https://apps.who.int/iris/handle/10665/342235</a>, accessed 6 July 2021).  </li>
      <li> Considerations for implementing and adjusting public health and social measures in the context of COVID-19. Interim guidance. Geneva: World Health Organization; 14 June 2021 <a href="https://www.who.int/publications/i/item/considerations-in-adjusting-public-health-and-social-measures-in-the-context-of-covid-19-interim-guidance">(https://www.who.int/publications/i/item/considerations-in-adjusting-public-health-and-social-measures-in-the-context-of-covid-19-interim-guidance</a>, accessed 27 June 2021).  </li>
      <li> Statement on the seventh meeting of the International Health Regulations  (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic. In: World Health Organization/News [website]; 19 April 2021 <a href="https://www.who.int/news/item/19-04-2021-statement-on-the-seventh-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic">(https://www.who.int/news/item/19-04-2021-statement-on-the-seventh-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic</a>, accessed 27 June 2021).  </li>
      <li> Statement on the sixth meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic. In: World Health Organization/News [website]; 15 January 2021 <a href="https://www.who.int/news/item/15-01-2021-statement-on-the-sixth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic">(https://www.who.int/news/item/15-01-2021-statement-on-the-sixth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic</a>, accessed 27 June 2021).  </li>
      <li> Interim position paper: considerations regarding proof of COVID-19 vaccination for international travellers. In: World Health Organization/Newsroom [website]; 5 February 2021 <a href="https://www.who.int/news-room/articles-detail/interim-position-paper-considerations-regarding-proof-of-covid-19-vaccination-for-international-travellers">(https://www.who.int/news-room/articles-detail/interim-position-paper-considerations-regarding-proof-of-covid-19-vaccination-for-international-travellers</a>, accessed 27 June 2021).  </li>
      <li> Monitoring COVID-19 vaccination: considerations for the collection and use of vaccination data. Interim guidance. Geneva: World Health Organization; 3 March 2021 <a href="https://www.who.int/publications/i/item/monitoring-covid-19-vaccination-interim-guidance">(https://www.who.int/publications/i/item/monitoring-covid-19-vaccination-interim-guidance</a>, accessed 27 June 2021).  </li>
      <li> Practical guide for the design, use and promotion of home-based records in immunization programmes. Geneva: World Health Organization; 1 June 2015 <a href="https://www.who.int/publications/i/item/WHO-IVB-15.05">(https://www.who.int/publications/i/item/WHO-IVB-15.05</a>, accessed 27 June 2021).  </li>
      <li> Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines. Geneva: World Health Organization; 1 June 2021 <a href="https://www.who.int/publications/i/item/WHO-2019-nCoV-Vaccine-deployment-2021.1-eng">(https://www.who.int/publications/i/item/WHO-2019-nCoV-Vaccine-deployment-2021.1-eng</a>, accessed 27 June 2021).  </li>
      <li> International Health Regulations (2005), third edition. Geneva: World Health Organization; 1 January 2016 <a href="https://www. who.int/publications/i/item/9789241580496">(https://www. who.int/publications/i/item/9789241580496</a>, accessed 27 June 2021).  </li>
      <li> Guidelines: visible digital seals (“VDS-NC”) for travel-related health proofs. International Civil Aviation Organization (ICAO) Technical Advisory Group (TAG) on the Traveler Identification Group (TRIP); no date <a href="https://www.icao.int/Security/FAL/TRIP/PublishingImages/Pages/Publications/Guidelines%20-%20VDS%20for%20Travel-Related%20Public%20 Health%20Proofs.pdf">(https://www.icao.int/Security/FAL/TRIP/PublishingImages/Pages/Publications/Guidelines%20-%20VDS%20for%20Travel-Related%20Public%20 Health%20Proofs.pdf</a>, accessed 27 June 2021).  </li>
      <li> EU Digital COVID certificate. In: European Commission [website]; no date <a href="https://ec.europa.eu/info/live-work-travel-eu/ coronavirus-response/safe-covid-19-vaccines-europeans/eu-digital-covid-certificate_en#what-is-the-eu-digital-covid-certificate">(https://ec.europa.eu/info/live-work-travel-eu/ coronavirus-response/safe-covid-19-vaccines-europeans/eu-digital-covid-certificate_en#what-is-the-eu-digital-covid-certificate</a>, accessed 27 June 2021).  </li>
     </ul>

    <h4> Ethical considerations and data protection principles</h4>
    <ul>
      <li> Requiring proof of Covid-19 vaccination (vaccine “passports”/“certificates”): Key ethical, legal, and social issues. Policy brief. In: Swiss National COVID-19 Science Task Force [website]. Zurich: ETH Board; 19 February 2021 <a href="https://sciencetaskforce.ch/en/policy-brief/requiring-proof-of-covid-19-vaccination-vaccine-passports-certificates-key-ethical-legal-and-social-issues">(https://sciencetaskforce.ch/en/policy-brief/requiring-proof-of-covid-19-vaccination-vaccine-passports-certificates-key-ethical-legal-and-social-issues</a>, accessed 27 June 2021).  </li>
      <li> Ozawa S, Yemeke TT, Evans DR, Pallas SE, Wallace AS, Lee BY. Defining hard-to-reach populations for vaccination. Vaccine. 2019;37 (37):5525–34. doi:10.1016/j.vaccine.2019.06.081. </li>
      <li> What place should COVID-19 vaccine passports have in society?. Ada Lovelace Institute; 17 February 2021 <a href="https://www. adalovelaceinstitute.org/wp-content/uploads/2021/02/COVID-19-vaccine-passports-rapid-expert-deliberation.pdf">(https://www. adalovelaceinstitute.org/wp-content/uploads/2021/02/COVID-19-vaccine-passports-rapid-expert-deliberation.pdf</a>, accessed 27 June 2021).  </li>
      <li> Committee on Bioethics. Statement on human rights considerations relevant to “vaccine pass” and similar documents. Strasbourg: Council of Europe; 4 May 2021 <a href="https://rm.coe.int/dh-bio-2021-7-final-statement-vaccines-e/1680a259dd">(https://rm.coe.int/dh-bio-2021-7-final-statement-vaccines-e/1680a259dd</a>, accessed 27 June 2021).  </li>
      <li> COVID-19 Vaccination certificates and lifting public health and social measures: ethical considerations. Geneva: World Health Organization; forthcoming.  </li>
      <li> Twelve criteria for the development and use of COVID-19 vaccine passports. Pre-print paper. London: The Royal Society The Royal Society SET-C (Science in Emergencies Tasking – COVID); 14 February 2021 <a href="https://royalsociety.org/-/media/ policy/projects/set-c/set-c-vaccine-passports.pdf">(https://royalsociety.org/-/media/ policy/projects/set-c/set-c-vaccine-passports.pdf</a>, accessed 27 June 2021).  </li>
      <li> Voo TC, Reis AA, Thomé B, Ho CW, Tam CC, Kelly-Cirino C, et al. Immunity certification for COVID-19: ethical considerations. Bulletin of the World Health Organization. 2021;99 (2):155–61. doi:10.2471/BLT.20.280701.  </li>
      <li> Guidelines on ethical issues in public health surveillance. Geneva: World Health Organization, 2017 <a href="https://www.who.int/ publications/i/item/who-guidelines-on-ethical-issues-in-public-health-surveillance">(https://www.who.int/ publications/i/item/who-guidelines-on-ethical-issues-in-public-health-surveillance</a>, accessed 27 June 2021).  </li>
     </ul>
 
    <h4> DDCC:VS Core data set</h4>
     <ul>
      <li> Global manual on surveillance of adverse events following immunization. Geneva: World Health Organization, 2016, <a href="https://apps.who.int/iris/handle/10665/206144">(https://apps.who.int/iris/handle/10665/206144</a>, accessed 27 June 2021).  </li>
      <li> International Patient Summary Implementation Guide: 1.0.0 – Continuous Integration Build [website]. Health Level Seven International – Patient Care Work Group; 2021 <a href="https://build.fhir.org/ig/HL7/fhir-ips">(https://build.fhir.org/ig/HL7/fhir-ips</a>, accessed 27 June 2021).  </li>
      <li> ICD-11: International Classification of Diseases 11th Revision. In: World Health Organization International Classification of Diseases [website]. Geneva: World Health Organization; 2021 <a href="https://icd.who.int/en">(https://icd.who.int/en</a>, accessed 27 June 2021).  </li>
      <li> Global Patient Set. In: SNOMED International [website]. London: SNOMED International; 2021 <a href="https://www.snomed.org/ snomed-international/learn-more/global-patient-set">(https://www.snomed.org/ snomed-international/learn-more/global-patient-set</a>, accessed 27 June 2021).  </li>
     </ul>

    <h4> National governance considerations</h4>
    <ul>
      <li> Health system governance. In: World Health Organization/Health topics [website]. Geneva: World Health Organization; no date <a href="https://www.who.int/health-topics/health-systems-governance#tab=tab_1">(https://www.who.int/health-topics/health-systems-governance#tab=tab_1</a>, accessed 27 June 2021).  </li>
      <li> Adams C, Farrell S, Kause T, Mononen T. Internet X.509 Public Key Infrastructure Certificate Management Protocol (CMP), section 3.1.1.2 Certification Authority. Reston (VA) and Geneva: The Internet Society Network Working Group; 2005 <a href="https://datatracker.ietf.org/doc/html/rfc4210#section-3.1.1.2">(https://datatracker.ietf.org/doc/html/rfc4210#section-3.1.1.2</a>, accessed 27 June 2021).  </li>
     </ul>

    <h4> Implementation considerations</h4>
    <ul>
      <li> Budd J, Miller BS, Manning EM, Lampos V, Zhuang M, Edelstein M, et al. Digital technologies in the public-health response to COVID-19. Nat Med. 2020;26 (8):1183–92. doi:10.1038/s41591-020-1011-4.  </li>
      <li> National eHealth Strategy Toolkit: overview. Geneva: World Health Organization and International Telecommunication Union; 2012 <a href="https://www.who.int/ehealth/publications/overview.pdf">(https://www.who.int/ehealth/publications/overview.pdf</a>, accessed 28 June 2021).  </li>
      <li> Digital implementation investment guide (DIIG): integrating digital interventions into health programmes. Geneva: World Health Organization; 15 September 2020 <a href="https://www.who.int/publications/i/item/9789240010567">(https://www.who.int/publications/i/item/9789240010567</a>, accessed 28 June 2021).  </li>
      <li> Rwanda uses DHIS2 as an interactive system for rapid and paperless COVID-19 vaccination. In: dhis2 [website]. University of Oslo; no date <a href="https://dhis2.org/rwanda-covid-vaccination">(https://dhis2.org/rwanda-covid-vaccination</a>, accessed 28 June 2021).  </li>
      <li> DIVOC Digital Infrastructure for Vaccination Open Credentialing. In: DIVOC [website]. India: eGov Foundation; no date <a href="https://divoc.egov.org.in">(https://divoc.egov.org.in</a>, accessed 28 June 2021).  </li>
     </ul>
  
    <h4> Introduction</h4>
    <ul>
      <li> Interim international health regulations position paper. Geneva: World Health Organization (forthcoming).  </li>
      <li> Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19. Geneva: World Health Organization; 2 July 2021 <a href="https://apps.who.int/iris/handle/10665/342235">(https://apps.who.int/iris/handle/10665/342235</a>, accessed 6 July 2021).  </li>
      <li> Considerations for implementing and adjusting public health and social measures in the context of COVID-19. Interim guidance. Geneva: World Health Organization; 14 June 2021 <a href="https://www.who.int/publications/i/item/considerations-in-adjusting-public-health-and-social-measures-in-the-context-of-covid-19-interim-guidance">(https://www.who.int/publications/i/item/considerations-in-adjusting-public-health-and-social-measures-in-the-context-of-covid-19-interim-guidance</a>, accessed 27 June 2021).  </li>
      <li> Statement on the seventh meeting of the International Health Regulations  (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic. In: World Health Organization/News [website]; 19 April 2021 <a href="https://www.who.int/news/item/19-04-2021-statement-on-the-seventh-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic">(https://www.who.int/news/item/19-04-2021-statement-on-the-seventh-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic</a>, accessed 27 June 2021).  </li>
      <li> Statement on the sixth meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic. In: World Health Organization/News [website]; 15 January 2021 <a href="https://www.who.int/news/item/15-01-2021-statement-on-the-sixth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic">(https://www.who.int/news/item/15-01-2021-statement-on-the-sixth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic</a>, accessed 27 June 2021).  </li>
      <li> Interim position paper: considerations regarding proof of COVID-19 vaccination for international travellers. In: World Health Organization/Newsroom [website]; 5 February 2021 <a href="https://www.who.int/news-room/articles-detail/interim-position-paper-considerations-regarding-proof-of-covid-19-vaccination-for-international-travellers">(https://www.who.int/news-room/articles-detail/interim-position-paper-considerations-regarding-proof-of-covid-19-vaccination-for-international-travellers</a>, accessed 27 June 2021).  </li>
      <li> Monitoring COVID-19 vaccination: considerations for the collection and use of vaccination data. Interim guidance. Geneva: World Health Organization; 3 March 2021 <a href="https://www.who.int/publications/i/item/monitoring-covid-19-vaccination-interim-guidance">(https://www.who.int/publications/i/item/monitoring-covid-19-vaccination-interim-guidance</a>, accessed 27 June 2021).  </li>
      <li> Practical guide for the design, use and promotion of home-based records in immunization programmes. Geneva: World Health Organization; 1 June 2015 <a href="https://www.who.int/publications/i/item/WHO-IVB-15.05">(https://www.who.int/publications/i/item/WHO-IVB-15.05</a>, accessed 27 June 2021).  </li>
      <li> Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines. Geneva: World Health Organization; 1 June 2021 <a href="https://www.who.int/publications/i/item/WHO-2019-nCoV-Vaccine-deployment-2021.1-eng">(https://www.who.int/publications/i/item/WHO-2019-nCoV-Vaccine-deployment-2021.1-eng</a>, accessed 27 June 2021).  </li>
      <li> International Health Regulations (2005), third edition. Geneva: World Health Organization; 1 January 2016 <a href="https://www. who.int/publications/i/item/9789241580496">(https://www. who.int/publications/i/item/9789241580496</a>, accessed 27 June 2021).  </li>
      <li> Guidelines: visible digital seals (“VDS-NC”) for travel-related health proofs. International Civil Aviation Organization (ICAO) Technical Advisory Group (TAG) on the Traveler Identification Group (TRIP); no date <a href="https://www.icao.int/Security/FAL/TRIP/PublishingImages/Pages/Publications/Guidelines%20-%20VDS%20for%20Travel-Related%20Public%20 Health%20Proofs.pdf">(https://www.icao.int/Security/FAL/TRIP/PublishingImages/Pages/Publications/Guidelines%20-%20VDS%20for%20Travel-Related%20Public%20 Health%20Proofs.pdf</a>, accessed 27 June 2021).  </li>
      <li> EU Digital COVID certificate. In: European Commission [website]; no date <a href="https://ec.europa.eu/info/live-work-travel-eu/ coronavirus-response/safe-covid-19-vaccines-europeans/eu-digital-covid-certificate_en#what-is-the-eu-digital-covid-certificate">(https://ec.europa.eu/info/live-work-travel-eu/ coronavirus-response/safe-covid-19-vaccines-europeans/eu-digital-covid-certificate_en#what-is-the-eu-digital-covid-certificate</a>, accessed 27 June 2021).  </li>
     </ul>

    <h4> Ethical considerations and data protection principles</h4>
    <ul>
      <li> Requiring proof of Covid-19 vaccination (vaccine “passports”/“certificates”): Key ethical, legal, and social issues. Policy brief. In: Swiss National COVID-19 Science Task Force [website]. Zurich: ETH Board; 19 February 2021 <a href="https://sciencetaskforce.ch/en/policy-brief/requiring-proof-of-covid-19-vaccination-vaccine-passports-certificates-key-ethical-legal-and-social-issues">(https://sciencetaskforce.ch/en/policy-brief/requiring-proof-of-covid-19-vaccination-vaccine-passports-certificates-key-ethical-legal-and-social-issues</a>, accessed 27 June 2021).  </li>
      <li> Ozawa S, Yemeke TT, Evans DR, Pallas SE, Wallace AS, Lee BY. Defining hard-to-reach populations for vaccination. Vaccine. 2019;37 (37):5525–34. doi:10.1016/j.vaccine.2019.06.081. </li>
      <li> What place should COVID-19 vaccine passports have in society?. Ada Lovelace Institute; 17 February 2021 <a href="https://www. adalovelaceinstitute.org/wp-content/uploads/2021/02/COVID-19-vaccine-passports-rapid-expert-deliberation.pdf">(https://www. adalovelaceinstitute.org/wp-content/uploads/2021/02/COVID-19-vaccine-passports-rapid-expert-deliberation.pdf</a>, accessed 27 June 2021).  </li>
      <li> Committee on Bioethics. Statement on human rights considerations relevant to “vaccine pass” and similar documents. Strasbourg: Council of Europe; 4 May 2021 <a href="https://rm.coe.int/dh-bio-2021-7-final-statement-vaccines-e/1680a259dd">(https://rm.coe.int/dh-bio-2021-7-final-statement-vaccines-e/1680a259dd</a>, accessed 27 June 2021).  </li>
      <li> COVID-19 Vaccination certificates and lifting public health and social measures: ethical considerations. Geneva: World Health Organization; forthcoming.  </li>
      <li> Twelve criteria for the development and use of COVID-19 vaccine passports. Pre-print paper. London: The Royal Society The Royal Society SET-C (Science in Emergencies Tasking – COVID); 14 February 2021 <a href="https://royalsociety.org/-/media/ policy/projects/set-c/set-c-vaccine-passports.pdf">(https://royalsociety.org/-/media/ policy/projects/set-c/set-c-vaccine-passports.pdf</a>, accessed 27 June 2021).  </li>
      <li> Voo TC, Reis AA, Thomé B, Ho CW, Tam CC, Kelly-Cirino C, et al. Immunity certification for COVID-19: ethical considerations. Bulletin of the World Health Organization. 2021;99 (2):155–61. doi:10.2471/BLT.20.280701.  </li>
      <li> Guidelines on ethical issues in public health surveillance. Geneva: World Health Organization, 2017 <a href="https://www.who.int/ publications/i/item/who-guidelines-on-ethical-issues-in-public-health-surveillance">(https://www.who.int/ publications/i/item/who-guidelines-on-ethical-issues-in-public-health-surveillance</a>, accessed 27 June 2021).  </li>
     </ul>
 
    <h4> DDCC:VS Core data set</h4>
     <ul>
      <li> Global manual on surveillance of adverse events following immunization. Geneva: World Health Organization, 2016, <a href="https://apps.who.int/iris/handle/10665/206144">(https://apps.who.int/iris/handle/10665/206144</a>, accessed 27 June 2021).  </li>
      <li> International Patient Summary Implementation Guide: 1.0.0 – Continuous Integration Build [website]. Health Level Seven International – Patient Care Work Group; 2021 <a href="https://build.fhir.org/ig/HL7/fhir-ips">(https://build.fhir.org/ig/HL7/fhir-ips</a>, accessed 27 June 2021).  </li>
      <li> ICD-11: International Classification of Diseases 11th Revision. In: World Health Organization International Classification of Diseases [website]. Geneva: World Health Organization; 2021 <a href="https://icd.who.int/en">(https://icd.who.int/en</a>, accessed 27 June 2021).  </li>
      <li> Global Patient Set. In: SNOMED International [website]. London: SNOMED International; 2021 <a href="https://www.snomed.org/ snomed-international/learn-more/global-patient-set">(https://www.snomed.org/ snomed-international/learn-more/global-patient-set</a>, accessed 27 June 2021).  </li>
     </ul>

    <h4> National governance considerations</h4>
    <ul>
      <li> Health system governance. In: World Health Organization/Health topics [website]. Geneva: World Health Organization; no date <a href="https://www.who.int/health-topics/health-systems-governance#tab=tab_1">(https://www.who.int/health-topics/health-systems-governance#tab=tab_1</a>, accessed 27 June 2021).  </li>
      <li> Adams C, Farrell S, Kause T, Mononen T. Internet X.509 Public Key Infrastructure Certificate Management Protocol (CMP), section 3.1.1.2 Certification Authority. Reston (VA) and Geneva: The Internet Society Network Working Group; 2005 <a href="https://datatracker.ietf.org/doc/html/rfc4210#section-3.1.1.2">(https://datatracker.ietf.org/doc/html/rfc4210#section-3.1.1.2</a>, accessed 27 June 2021).  </li>
     </ul>

    <h4> Implementation considerations</h4>
    <ul>
      <li> Budd J, Miller BS, Manning EM, Lampos V, Zhuang M, Edelstein M, et al. Digital technologies in the public-health response to COVID-19. Nat Med. 2020;26 (8):1183–92. doi:10.1038/s41591-020-1011-4.  </li>
      <li> National eHealth Strategy Toolkit: overview. Geneva: World Health Organization and International Telecommunication Union; 2012 <a href="https://www.who.int/ehealth/publications/overview.pdf">(https://www.who.int/ehealth/publications/overview.pdf</a>, accessed 28 June 2021).  </li>
      <li> Digital implementation investment guide (DIIG): integrating digital interventions into health programmes. Geneva: World Health Organization; 15 September 2020 <a href="https://www.who.int/publications/i/item/9789240010567">(https://www.who.int/publications/i/item/9789240010567</a>, accessed 28 June 2021).  </li>
      <li> Rwanda uses DHIS2 as an interactive system for rapid and paperless COVID-19 vaccination. In: dhis2 [website]. University of Oslo; no date <a href="https://dhis2.org/rwanda-covid-vaccination">(https://dhis2.org/rwanda-covid-vaccination</a>, accessed 28 June 2021).  </li>
      <li> DIVOC Digital Infrastructure for Vaccination Open Credentialing. In: DIVOC [website]. India: eGov Foundation; no date <a href="https://divoc.egov.org.in">(https://divoc.egov.org.in</a>, accessed 28 June 2021).  </li>
      </ul>
</div>
